Jeff Yass’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$268K Buy
43,075
+19,946
+86% +$115K ﹤0.01% 11236
2026
Q2
$141K Buy
+23,129
New +$555K ﹤0.01% 12254

Other funds holding RGC

Jeff Yass's RGC Position: Q3 2026 in Review

Jeff Yass increased its Regencell Bioscience (RGC) stake by 86% in Q3 2026, buying an estimated $115K and bringing the position to 43,075 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #11236.

Jeff Yass first reported a position in RGC in Q2 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Jeff Yass held 43,075 shares of Regencell Bioscience worth $268K as of Q3 2026.
  • Jeff Yass bought 19,946 Regencell Bioscience shares in Q3 2026, an estimated $115K.
  • Regencell Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11236 holding.
  • Jeff Yass first reported a position in Regencell Bioscience in Q2 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.